Heart failure Circulatory System
Conditions
Interventions
Before conducting the education sessions, the pharmacists will review the patients’ medical records, including medications and laboratory data, using the portal system. This review is part of their st
Sponsors
National Taiwan University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with heart failure and a documented left ventricular ejection fraction (LVEF) <40%
Exclusion criteria
Exclusion criteria: 1. Patients unable to provide full informed consent 2. Patients unable to comply with study procedures 3. Patients unable to complete the required questionnaires in person on three occasions or return for follow-up visits 4. Patients who cannot understand or respond to the required questionnaires
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medication adherence will be assessed using the Morisky 8-item Medication Adherence Scale (MMAS-8) at baseline (T0), 3 months (T1), and 6 months (T2) after randomization. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Patient satisfaction with pharmacist services will be evaluated using the adapted Chinese version of the Patient Satisfaction with Pharmacist Services Questionnaire 2.0 (C-PSPSQ 2.0) at baseline (T0), 3 months (T1), and 6 months (T2) after randomization. 2. Facilitators and barriers to the implementation: To explore potential facilitators and barriers to the implementation of the dashboard, a subgroup of pharmacists and patients will complete the Acceptability of Intervention Measure, Intervention Appropriateness Measure, and Feasibility of Intervention Measure (AIM-IAM-FIM) questionnaire at 6 months (T2) after randomization. | — |
Countries
Taiwan
Contacts
Public ContactWan-Tseng Hsu
Outcome results
None listed